Adaptive Biotechnologies announced plans to lease a new corporate headquarters, tripling the company’s footprint in Seattle.
EVERSANA, a leading independent provider of global commercial services to the life science industry, announced the rapid expansion of the company’s Asia Pacific business with the addition of two new offices in Singapore and Mumbai.
Internationally recognized healthcare marketing strategy firm 2e Creative joined the Fishawack Group after receiving investment from the global healthcare communications group.
Contract research organization Catalent plans to buy Bristol-Myers Squibb’s manufacturing and packaging factory in Anagni, Italy, used to manufacture oral solid, biologics and sterile products.
FreshBlood Health Market Consultants, which was launched in 2015 by prominent healthcare industry marketing expert Robert Finkel, announced the life-science solutions provider’s expanded creative services capabilities and official reconfiguration as FreshBlood Group.
Months after securing $72 million in a Series C financing round and expanding a developmental agreement with pharma giant Roche worth up to $1 billion, SQZ Biotech is expanding the company’s footprint in Watertown, Mass.
Regeneron plans to invest more than $800 million over seven years to expand the company’s facilities in Rensselaer County, New York. This expansion is expected to create 1,500 new full-time jobs.
Backed by financing from a collaboration with Novartis and an $83 million financing round, Homology Medicines is moving to a new facility with more than triple the space of its headquarters.
W2O Group, a network of innovative analytics-driven, digital-first marketing and communications firms, announced the appointment of three senior executives in its growing Chicago office.
Precision Value & Health announced the formation of Precision Xtract – a new, focused alignment of the company’s global market access consulting services.